Nephropathy, Diabetic
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy (NCT04534439) | Aptabio Therapeutics, Inc. | 2020-08-24 |
Track Nephropathy, Diabetic automatically
Every clearance here is in the API, with alerts when new ones post.